In today’s environment where drug companies are being monitored closely (take TAP’s recent lawsuit in the Boston area for instance) for physician kickbacks for prescribing drugs, comes this story from Italy:
A two-year investigation by the financial brigade found that the Italian subsidiary of Glaxo had mounted an illegal incentives scheme involving 4,713 people, including 4,440 doctors.
Glaxo clearly wasn’t subtle in their efforts to influence physicians:
. . . Freebies doled out to doctors across Italy included all-expenses-paid travel, cash or free pharmaceutical drugs, the police found.